| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.38M | $170.65M | - | |
| CEO | 324.9K | $40.10M | - | |
| CFO | 99.2K | $12.25M | - | |
| Other | 86.8K | $10.72M | -5,500 | |
| Other | 83.4K | $10.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | Noci Darlene | Chief Development Officer | Sale+OE | 3,000 | $52.66 | $157,975.07 | -43.5% | +41.0% | +64.8% | |
| Oct 24, 2023 | Shair Matthew45 | Director | Sell | 91,700 | $50.70 | $4,648,872.40 | -2.4% | +52.9% | +80.6% | |
| Oct 4, 2023 | Noci Darlene | Chief Development Officer | Sale+OE | 20,000 | $55.99 | $1,119,702.00 | -78.7% | +32.3% | +80.0% | |
| Oct 4, 2023 | Turner Christopher Durant | Chief Medical Officer | Sale+OE | 7,995 | $54.04 | $432,030.80 | -7.3% | +32.3% | +80.0% | |
| Oct 2, 2023 | Noci Darlene | Chief Development Officer | Sale+OE | 3,000 | $45.88 | $137,649.30 | -55.9% | +66.1% | +124.9% | |
| Sep 15, 2023 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 2,000 | $47.64 | $95,283.36 | -72.6% | +66.8% | +84.6% | |
| Sep 1, 2023 | Noci Darlene | Chief Development Officer | Sale+OE | 3,000 | $46.56 | $139,692.00 | -62.5% | +40.7% | +83.2% | |
| Aug 15, 2023 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 2,000 | $42.65 | $85,309.95 | -73.8% | +34.9% | +66.0% | |
| Aug 1, 2023 | Noci Darlene | Chief Development Officer | Sale+OE | 3,000 | $49.95 | $149,843.68 | -59.6% | +3.0% | +63.0% | |
| Jul 31, 2023 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 25,000 | $48.99 | $1,224,796.24 | -69.7% | +1.3% | +56.3% |